Arrhythmia Alliance News & Events
World Heart Rhythm Week 2018 - Take Fainting to Heart
The first Heart Rhythm Week pioneered by the Arrhythmia Alliance UK was celebrated in 2004. The organization has been actively striving through its campaigns to promote early diagnosis and treatment as well as improve quality of life of persons affected by arrhythmias.
The good doctors guide: Meet the best heart rhythm surgeons in Britain and learn the cutting-edge treatments used to correct deadly flutters
What are the hallmarks of a good doctor? Skill and technical expertise, of course. But also vital is someone who understands you and someone you trust.
A deeper understanding of AFib could lower risk
More than 2.5 million Americans are living with Atrial Fibrillation (AFib). AFib is an irregular heartbeat that can lead to blood clots, stroke, heart failure ...
Inflammatory signals in heart muscle cells linked to atrial fibrillation
nterfering with inflammatory signals produced by heart muscle cells might someday provide novel therapeutic strategies for atrial fibrillation, according to an international team of researchers.
Cardiac rhythm News - 1 June 2018
Here is all the latest Cardiac Rhythm News.
Surgical treatment of atrial fibrillation results in higher complication rates when compared to catheter ablation
The total procedure-related complications after surgical minimally invasive pulmonary vein isolations (MIPI) were higher; this was mainly due to more major complications. During a two-year follow-up there were three transient ischaemic attacks or cerebrovascular accidents after MIPI compared to zero after catheter ablation.
Apixaban is a safe alternative to warfarin during catheter ablation of atrial fibrillation and may have a positive effect on cognitive function
Apixaban and warfarin are equally safe during catheter ablation of atrial fibrillation, according to results of the AXAFA-AFNET 5 (Anticoagulation using the direct factor Xa inhibitor apixaban during Atrial Fibrillation catheter Ablation: Comparison to vitamin K antagonist therapy) (German Atrial Fibrillation NETwork (AFNET)) trial presented at European Heart Rhythm Association Congress (EHRA; 18–20 March 2018, Barcelona, Spain). There were similar rates of stroke and bleeding, and an improvement in cognitive function was shown for the first time.
European Sudden Cardiac Arrest network will look at gender-based prevention and treatment
Researchers will use a European network of 90,000 patients, including 20,000 DNA samples, to look at different approaches for prevention and treatment of sudden cardiac arrest for men and women.